We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 14 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 40 actions collected · 21 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 08. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 05. 08. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 04. 16. | Citigroup | — | Initiate coverage | — → Buy | — | Citigroup: Buy |
| 2026. 02. 26. | Morgan Stanley | — | Maintain | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2026. 02. 25. | Keybanc | — | Maintain | Overweight → Overweight | — | Keybanc: Overweight |
| 2026. 02. 25. | Leerink Partners | — | Maintain | Outperform → Outperform | — | Leerink Partners: Outperform |
| 2026. 02. 20. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 01. 22. | Piper Sandler | — | Upgrade | Neutral → Overweight | — | Piper Sandler: Neutral → Overweight |
| 2025. 12. 19. | Morgan Stanley | — | Maintain | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2025. 12. 10. | Barclays | — | Initiate coverage | — → Overweight | — | Barclays: Overweight |
| 2025. 11. 21. | Keybanc | — | Initiate coverage | — → Overweight | — | Keybanc: Overweight |
| 2025. 11. 07. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 10. 21. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 10. 07. | JP Morgan | — | Upgrade | Neutral → Overweight | — | JP Morgan: Neutral → Overweight |
| 2025. 09. 25. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2025. 08. 11. | Piper Sandler | — | Maintain | Neutral → Neutral | — | Piper Sandler: Neutral |
| 2025. 08. 09. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 07. 24. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 07. 17. | Leerink Partners | — | Upgrade | Market Perform → Outperform | — | Leerink Partners: Market Perform → Outperform |
| 2025. 07. 03. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2025. 06. 26. | William Blair | — | Upgrade | Market Perform → Outperform | — | William Blair: Market Perform → Outperform |
| 2025. 05. 19. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2025. 05. 08. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2025. 04. 14. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2025. 03. 06. | Piper Sandler | — | Maintain | Neutral → Neutral | — | Piper Sandler: Neutral |
| 2025. 02. 27. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 02. 27. | Morgan Stanley | — | Maintain | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2025. 02. 26. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2025. 02. 26. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 02. 21. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2025. 01. 30. | Morgan Stanley | — | Maintain | Equal-Weight → Equal-Weight | — | Morgan Stanley: Equal-Weight |
| 2025. 01. 08. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2024. 12. 09. | UBS | — | Initiate coverage | — → Buy | — | UBS: Buy |
| 2024. 12. 02. | Leerink Partners | — | Initiate coverage | — → Market Perform | — | Leerink Partners: Market Perform |
| 2024. 11. 09. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 10. 28. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 09. 23. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 09. 20. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2024. 09. 19. | Morgan Stanley | — | Downgrade | Overweight → Equal-Weight | — | Morgan Stanley: Overweight → Equal-Weight |
| 2024. 07. 01. | Piper Sandler | — | Maintain | Neutral → Neutral | — | Piper Sandler: Neutral |